Breaking Convention: Here & Now - Between the History and Future of Psychedelics

Livestream tickets for the one-day event, taking place this Saturday 20th April, are still available...

tickettailor.com/events/breakin…

Pα+ Psychedelic Bulletin #161

Numinus Shifts Focus to US

Algernon Makes DMT for Stroke Lead Asset

atai Pivots to IV Ibogaine

Petition Calls on FDA to Convene Open Advisory Committee Meeting

and more...

psychedelicalpha.com/news/p%ce%b1-p…

Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran Singh

psychedelicalpha.com/news/developin…

Real-time updates on psychedelics-related legal cases?

Psychedelic Cases Bot Psychedelic Cases Bot—a fantastic resource, if you're not yet familiar

Brainchild of Laurel Kilgour, from Free Law Project ⚖ 🦋 & curated by Psychedelic Alpha & Psychedelic Bar Assoc

Follow & reach out to add more cases:

Invaluable information and analysis from Psychedelic Alpha. If you follow the psychedelics space closely, a subscription to pa+ is worth every single penny.

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around Its Role in Psychedelic Therapies

We look at MindMed's claim to have ‘eliminated’ psychotherapy from its Phase 2b study and explore the broader ‘Spravato-isation’ of PATs.

psychedelicalpha.com/news/mindmeds-…

Interview: Senator Kirk Cullimore on Utah’s MDMA and Psilocybin Pilot Program

psychedelicalpha.com/news/senator-k…

It's not every day you get to bring an extradimensional technology into the 3rd dimension.

Stoked to finally share some details on this groundbreaking communication device enabling non-3D entities to communicate with humans!

I wonder if there will be challenges to patenting the ability to communicate with extra-dimensional entities with psychedelics. Is there prior art that is being ignored with all the DMT accounts? But I have to say, it's an absolutely perfect day for making such an announcement.

Interdimensional communication device?

Pleased to have helped prepare new patent application published today

We believe it is the first filed by a transdimensional being

Technology covers seamless communication for higher dimension-native entities with 3D-native travelers

1/3

“Deuterium assisted psychotherapy” got me 😂

Psychedelic News Feed: April 1, 2024

We woke up to some bizarre headlines from around the psychedelics world.

Read today's special edition of the Psychedelic News Feed:
psychedelicalpha.com/news/the-psych…

Please join me in welcoming Noah Smith to Calyx Law!

If you’ve followed Psychedelic Alpha you’ve surely appreciated Noah’s work, from drafting deep analyses of new developments, to keeping IP & legal trackers running

Delighted to bring Noah onto our team as a Patent Analyst

1/2

Pα+ Psychedelic Bulletin #160

- Mutual Recognition for MDMA-AT in the UK?

-Beckley Shares Cut of 5-MeO-DMT Data

- and more...

psychedelicalpha.com/news/p%ce%b1-p…

ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence “Insufficient”

psychedelicalpha.com/news/icer-draf…

atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of Intranasal 5-MeO-DMT in Treatment Resistant Depression

Rapid and durable antidepressant effect; 45% in clinical remission at week 12.

globenewswire.com/news-release/2…

People often learn about psychedelics from a growing number of articles, podcasts & documentaries. I have long wondered how media might influence research participants, and this scale will measure that! Honored to play a small role in its creation, please help us to validate it:

Ibogaine is Unlikely to Ever Receive Approval for Opioid Addiction, Says NIDA Director Nora Volkow

statnews.com/2024/03/21/ibo…

Pα+ Psychedelic Bulletin #159

Patient Access re: MDMA-Assisted Therapy

Doblin on the ‘Future of Psychedelics’

Whole Mushroom vs. Synthetic Psilocybin

Usona Launches Phase 3 Study

BTDs Attract Investors for MindMed and Cybin

And more...

psychedelicalpha.com/news/p%ce%b1-p…